Abstract
This study was conducted to elucidate patients with early breast cancer preference for standard whole breast irradiation (WBI) or partial breast irradiation (PBI) following lumpectomy, as well as identify important factors for patients when making their treatment decisions. Based on relevant literature and ASTRO consensus statement guidelines, an educational tool and questionnaire were developed. Consenting, eligible women reviewed the educational tool and completed the trade-off questionnaire. Descriptive statistics were calculated, as well as chi-squares and a logistic regression model. Of the 90 patients who completed the study, 62 % preferred WBI, 30 % preferred PBI, 4 % required more information, and 3 % had no preferences. Of the patients who chose WBI, 58 % preferred hypofractionated RT, whereas 25 % preferred the conventional RT regimen. The majority of patients rated recurrence rate [WBI = 55/55 (100 %), PBI = 26/26 (100 %)] and survival [WBI = 54/55 (98 %), PBI = 26/26 (100 %)] as important factors contributing to their choice of treatment preference. Financial factors [WBI = 21/55 (38 %), PBI = 14/26 (53 %)] and convenience [WBI = 36/54 (67 %), PBI = 18/26 (69 %)] were rated as important less frequently. Significantly, more patients who preferred WBI also rated standard method of treatment as important when compared to patients who preferred PBI [WBI = 52/54 (96 %), PBI = 16/26 (61 %), χ 2 = 16.63, p = 0.001]. The majority of patients with early breast cancer who were surveyed for this study preferred WBI as an adjuvant treatment post lumpectomy, yet there was a sizeable minority who preferred PBI. This was associated with the importance patients place on standard treatment. These results will help medical professionals treat patients according to patient values.
Similar content being viewed by others
References
Elkin E, Hudis C, Begg C, Schrag D (2005) The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999. Cancer 104(6):1149–1157
Anderson W, Jatoi I, Devesa SS (2006) Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943–2002). Breast Cancer Res Treat 99(3):333–340
Osteen R, Karnell LH (1994) The national cancer data base report on breast cancer. Cancer 73(7):1994–2000
Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232
Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241
Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 366:2087–2106
Smith B, Bentzen S, Correa CR et al (2011) Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 81(1):59–68
Suh W, Pierce LJ, Vicini FA, Hayman JA (2005) A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 62:790–796
Whelan T, Levine M, Julian J et al (2000) The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario clinical oncology group. Cancer 88:2260–2266
Yarnold, Magee JB, Bliss J et al (2008) The UK standardization of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet 371:1098–1107
Whelan T, Pignol J-P, Julian J et al (2008) Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node-negative breast cancer. Int J Radiat Oncol Biol Phys 72(1):S28
Yarnold J, Ashton A, Bliss J et al (2005) Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: longterm results of a randomised trial. Radiother Oncol 75:9–17
Whelan T, Pignol J-P, Levine M et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362:513–520
National Surgical Adjuvant Breast and Bowel Project (NSABP), & Radiation Therapy Oncology Group (RTOG). NSABP Protocol B-39/RTOG Protocol 0413. March 7, 2011. A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II Breast Cancer. Available from:http://rpc.mdanderson.org/rpc/credentialing/files/B39_Protocol1.pdf
Smith B, Arthur D, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74(4):987–1001
Vicini F, Beitsch PD, Quiet CA et al (2008) Three-year analysis of treatment efficacy, cosmesis, and toxicity by the american society of breast surgeons MammoSite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112:758–766
Pignol J-P, Rakovitch E, Keller B et al (2009) Tolerance and acceptance results of a palladium-103 permanent breast seed implant phase I/II study. Int J Radiat Oncol Biol Phys 73(5):1482–1488
Vaidky J, Joseph DJ, Tobias JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376(9735):91–102
Vicini F, Chen P, Wallace M et al (2007) Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 69:1124–1130
Vicini F, Winter K, Straube W et al (2005) A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of radiation therapy oncology group (RTOG) study 0319. Int J Radiat Oncol Biol Phys 63:1531–1537
Formenti S, Truong MT, Goldberg JD et al (2004) Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose–volume histogram analysis. Int J Radiat Oncol Biol Phys 60:493–504
Kozak K, Smith BL, Adams J et al (2006) Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys 66:691–698
Hoopes DJ, Kaziska D, Chapin P et al (2012) Patient preferences and physician practice patterns regarding breast radiotherapy. Int J Radiat Oncol Biol Phys 82(2):674–681
Hack T, Gedner LF, Watson P, Sinha L (2005) Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psych Oncol 15(1):9–19
Schroen AT, Petroni GR, Wang H et al (2012) Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. coop oncol group. Clin Cancer Res 18:256–262
Acknowledgments
Thank you to the patients who participated in this research project.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Online Resource 1
(DOCX 232 kb)
Rights and permissions
About this article
Cite this article
Bonin, K., McGuffin, M., Presutti, R. et al. Breast Cancer Patients’ Preferences for Adjuvant Radiotherapy Post Lumpectomy: Whole Breast Irradiation vs. Partial Breast Irradiation—Single Institutional Study. J Canc Educ 33, 37–43 (2018). https://doi.org/10.1007/s13187-016-1016-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-016-1016-3